Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 270 Companies   374 Products   374 Products   160 Mechanisms of Action   39 Trials   5519 News 


12345678910111213...110111»
  • ||||||||||  mapatumumab (HGS-ETR1) / GSK
    Phase classification, Combination therapy, Metastases:  Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer (clinicaltrials.gov) -  Apr 19, 2024   
    P1/2,  N=9, Completed, 
    Phase classification: P1/2 --> P1 | N=25 --> 12 Phase classification: P1b/2 --> P1/2
  • ||||||||||  Trial completion date, Trial primary completion date:  EC-02: The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma (clinicaltrials.gov) -  Apr 4, 2024   
    P=N/A,  N=240, Active, not recruiting, 
    Phase classification: P1b/2 --> P1/2 Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2023 --> Dec 2025
  • ||||||||||  Enrollment closed, Trial completion date, Trial primary completion date:  EC-02: The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma (clinicaltrials.gov) -  May 9, 2023   
    P=N/A,  N=240, Active, not recruiting, 
    N=300 --> 0 | Completed --> Withdrawn Recruiting --> Active, not recruiting | Trial completion date: Dec 2022 --> Dec 2025 | Trial primary completion date: Dec 2020 --> Dec 2023
  • ||||||||||  TroVax (MVA 5T4) / Oxford Biomedica
    Trial completion:  TRIOC: The Activity of TroVax (clinicaltrials.gov) -  May 9, 2019   
    P2,  N=94, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial completion date, Trial primary completion date:  Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) (clinicaltrials.gov) -  Apr 29, 2019   
    P=N/A,  N=500, Recruiting, 
    Active, not recruiting --> Terminated; The study was terminated upon completion of escalation phase, prior to opening expansion cohorts N=100 --> 500 | Trial completion date: Dec 2020 --> Dec 2025 | Trial primary completion date: Dec 2020 --> Dec 2025
  • ||||||||||  cisplatin / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date, Metastases:  DEPICT: Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer (clinicaltrials.gov) -  Apr 24, 2019   
    P1/2,  N=22, Completed, 
    N=100 --> 500 | Trial completion date: Dec 2020 --> Dec 2025 | Trial primary completion date: Dec 2020 --> Dec 2025 Active, not recruiting --> Completed | Trial completion date: Apr 2018 --> Jul 2018 | Trial primary completion date: Apr 2018 --> Jul 2018
  • ||||||||||  Trial completion:  C (clinicaltrials.gov) -  Apr 24, 2019   
    P=N/A,  N=900, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Apr 2018 --> Jul 2018 | Trial primary completion date: Apr 2018 --> Jul 2018 Active, not recruiting --> Completed
  • ||||||||||  Phase classification:  Healthy Eating for Reproductive Health (HERHealth) (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=18, Completed, 
    Active, not recruiting --> Completed Phase classification: P1/2 --> P=N/A
  • ||||||||||  Phase classification:  Healthy Eating for Reproductive Health: Greenville (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed Phase classification: P1 --> P=N/A
  • ||||||||||  Trial completion:  Community-Driven Cervical Cancer Prevention in Western Kenya (clinicaltrials.gov) -  Apr 19, 2019   
    P=N/A,  N=7200, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2019 --> Jan 2019 Active, not recruiting --> Completed
  • ||||||||||  Preclinical, Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer (clinicaltrials.gov) -  Apr 18, 2019   
    P=N/A,  N=138, Terminated, 
    Active, not recruiting --> Completed N=800 --> 138 | Trial completion date: Dec 2020 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Dec 2018; very slow recruitment
  • ||||||||||  Trial completion:  Hula, a Physical Activity Intervention for Female-Cancer Survivors (clinicaltrials.gov) -  Apr 18, 2019   
    P=N/A,  N=73, Completed, 
    N=800 --> 138 | Trial completion date: Dec 2020 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Dec 2018; very slow recruitment Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date, Surgery:  Surgicel Reduces Ovarian Endometriomas Recurrence (clinicaltrials.gov) -  Apr 16, 2019   
    P2,  N=200, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Apr 2018 --> Jan 2019 | Trial primary completion date: Apr 2018 --> Jan 2019
  • ||||||||||  Cervarix (recombinant human papillomavirus bivalent vaccine) / GSK, Japan Vaccine, Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
    Trial completion, Enrollment change:  CoheaHr-WP4: Comparing Health Services Interventions for the Prevention of HPV-related Cancer (clinicaltrials.gov) -  Apr 10, 2019   
    P4,  N=63, Completed, 
    Recruiting --> Completed | Trial completion date: Apr 2018 --> Jan 2019 | Trial primary completion date: Apr 2018 --> Jan 2019 Recruiting --> Completed | N=300 --> 63
  • ||||||||||  Trial completion, Trial primary completion date:  EnMotion, Embryo's Natural Motion (clinicaltrials.gov) -  Apr 5, 2019   
    P=N/A,  N=200, Completed, 
    Recruiting --> Completed | N=300 --> 63 Active, not recruiting --> Completed | Trial primary completion date: Oct 2018 --> May 2018
  • ||||||||||  CRS-207 / Novartis
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Combination therapy:  SEASCAPE: Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (clinicaltrials.gov) -  Apr 4, 2019   
    P1/2,  N=35, Terminated, 
    Recruiting --> Terminated; Terminated due to difficult recruitment N=126 --> 35 | Trial completion date: Dec 2018 --> May 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Apr 2018; Study was stopped due to low enrollment and lack of clinical activity.
  • ||||||||||  Trial completion, Phase classification, Trial completion date, Trial primary completion date:  ULMOST: Ultrasonic Versus Monopolar Energy-based Surgical Device in Colpotomy (clinicaltrials.gov) -  Apr 3, 2019   
    P=N/A,  N=40, Completed, 
    N=126 --> 35 | Trial completion date: Dec 2018 --> May 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Apr 2018; Study was stopped due to low enrollment and lack of clinical activity. Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Apr 2017 | Trial primary completion date: Apr 2018 --> Apr 2017
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Metastases:  CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (clinicaltrials.gov) -  Apr 2, 2019   
    P=N/A,  N=23, Terminated, 
    Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Apr 2018 --> Apr 2017 | Trial primary completion date: Apr 2018 --> Apr 2017 N=100000 --> 23 | Trial completion date: Oct 2019 --> Mar 2019 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2019 --> Mar 2019; Registry was built to handle Medicare coverage decision on NGS, but CMS decided to not require data.
  • ||||||||||  Menopur (menotropin) / Ferring
    Trial completion, Enrollment change:  A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility (clinicaltrials.gov) -  Mar 28, 2019   
    P=N/A,  N=412, Completed, 
    N=100000 --> 23 | Trial completion date: Oct 2019 --> Mar 2019 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2019 --> Mar 2019; Registry was built to handle Medicare coverage decision on NGS, but CMS decided to not require data. Recruiting --> Completed | N=2002 --> 412
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    Trial completion, Trial completion date:  TNFSF11 Inhibition and Fertility: a Prospective Study (clinicaltrials.gov) -  Mar 27, 2019   
    P2,  N=12, Completed, 
    Recruiting --> Completed | N=2002 --> 412 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019
  • ||||||||||  Trial completion, Trial primary completion date:  Clinical Tests to Predict the Success of Assisted Reproductive Techniques (clinicaltrials.gov) -  Mar 26, 2019   
    P=N/A,  N=542, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Oct 2018
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Sentinel Lymph Node Detection in Endometrial Cancer (clinicaltrials.gov) -  Mar 22, 2019   
    P=N/A,  N=257, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Oct 2018 Recruiting --> Completed | N=375 --> 257 | Trial completion date: Jun 2021 --> May 2018 | Trial primary completion date: Jun 2019 --> May 2018
  • ||||||||||  Trial completion, Enrollment change, Trial completion date:  Transperineal Ultrasound to Assess the Progress of Labour (clinicaltrials.gov) -  Mar 21, 2019   
    P=N/A,  N=297, Completed, 
    Recruiting --> Completed | N=375 --> 257 | Trial completion date: Jun 2021 --> May 2018 | Trial primary completion date: Jun 2019 --> May 2018 Recruiting --> Completed | N=700 --> 297 | Trial completion date: Oct 2018 --> Jan 2018
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date, Metastases:  Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy (clinicaltrials.gov) -  Mar 21, 2019   
    P=N/A,  N=107, Completed, 
    Recruiting --> Completed | N=700 --> 297 | Trial completion date: Oct 2018 --> Jan 2018 Recruiting --> Completed | N=180 --> 107 | Trial completion date: Feb 2020 --> Oct 2017 | Trial primary completion date: Feb 2020 --> Oct 2017
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Yoga Practice for Breast or Ovarian Cancer Patients (clinicaltrials.gov) -  Mar 14, 2019   
    P=N/A,  N=39, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Mar 2019 Active, not recruiting --> Completed | Trial completion date: Nov 2019 --> Mar 2019 | Trial primary completion date: Nov 2019 --> Mar 2019
  • ||||||||||  Enrollment change, Trial completion date, Trial termination:  Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions (clinicaltrials.gov) -  Mar 8, 2019   
    P=N/A,  N=5, Terminated, 
    N=300 --> 0 | Not yet recruiting --> Withdrawn N=300 --> 5 | Trial completion date: Sep 2019 --> Jun 2018 | Recruiting --> Terminated; Insufficient recruitment
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  PET CT With HX4 in Cervix Cancer (clinicaltrials.gov) -  Mar 8, 2019   
    P2,  N=4, Terminated, 
    Active, not recruiting --> Completed | Phase classification: P1 --> PN/A N=20 --> 4 | Trial completion date: Nov 2016 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: Nov 2016 --> May 2018; patients did not want to participate